- $23.78bn
- $27.17bn
- $8.12bn
- 97
- 37
- 92
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,806 | 2,797 | 5,481 | 7,741 | 8,120 |
Cost of Revenue | |||||
Gross Profit | 832 | 820 | 1,511 | 2,219 | 2,408 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,372 | 2,406 | 5,102 | 6,946 | 7,164 |
Operating Profit | 433 | 392 | 379 | 795 | 956 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 427 | 381 | 197 | 568 | 624 |
Provision for Income Taxes | |||||
Net Income After Taxes | 376 | 333 | 155 | 508 | 613 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 374 | 332 | 153 | 505 | 612 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 374 | 332 | 153 | 505 | 612 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.88 | 6.53 | 4.91 | 6.9 | 8.47 |